Annual report pursuant to Section 13 and 15(d)

Note 12 - Restructuring, Impairment and Plant Closing Costs

v3.22.4
Note 12 - Restructuring, Impairment and Plant Closing Costs
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Restructuring and Related Activities Disclosure [Text Block]

12. RESTRUCTURING, IMPAIRMENT AND PLANT CLOSING COSTS

 

As of  December 31, 2022, 2021 and 2020, accrued restructuring costs by type of cost consisted of the following (dollars in millions): 

 

           

Non-cancelable

   

Other

         
   

Workforce

   

lease and contract

   

Restructuring

         
   

reductions

   

termination costs

   

costs

   

Total

 

Accrued liabilities as of January 1, 2020

  $ 8     $ 4     $ 2     $ 14  

Charges

    28       2       4       34  

Payments

    (13 )     (6 )     (6 )     (25 )

Accrued liabilities as of December 31, 2020

    23                   23  

Charges

    17             5       22  

Payments

    (15 )           (4 )     (19 )

Accrued liabilities as of December 31, 2021

    25             1       26  

Charges

    69             11       80  

Payments

    (18 )           (12 )     (30 )

Accrued liabilities as of December 31, 2022

  $ 76     $     $     $ 76  

 

Details with respect to our reserves for restructuring, impairment and plant closing costs by segment are provided below (dollars in millions):

 

           

Performance

   

Advanced

   

Corporate

         
   

Polyurethanes

   

Products

   

Materials

   

and other

   

Total

 

Accrued liabilities as of January 1, 2020

  $     $     $ 10     $ 4     $ 14  

Charges

    16       5       7       6       34  

Payments

    (4 )     (3 )     (8 )     (10 )     (25 )

Accrued liabilities as of December 31, 2020

    12       2       9             23  

Charges (credits)

    6       2       (1 )     15       22  

Payments

    (9 )     (3 )     (3 )     (4 )     (19 )

Accrued liabilities as of December 31, 2021

    9       1       5       11       26  

Charges

    28       5       8       39       80  

Payments

    (13 )     (1 )     (3 )     (13 )     (30 )

Accrued liabilities as of December 31, 2022

  $ 24     $ 5     $ 10     $ 37     $ 76  
                                         

Current portion of restructuring reserves

  $ 24     $ 5     $ 10     $ 33     $ 72  

Long-term portion of restructuring reserves

                      4       4  

 

Details with respect to cash and noncash restructuring charges from continuing operations by initiative for the years ended December 31, 2022, 2021 and 2020 are provided below (dollars in millions):

 

Cash charges

  $ 80  

Noncash charges:

       

Gain on sale of assets

    (2 )

Accelerated depreciation

    6  

Other noncash charges

    2  

Total 2022 restructuring, impairment and plant closing costs

  $ 86  
         

Cash charges

  $ 22  

Noncash charges:

       

Gain on sale of assets

    (3 )

Accelerated depreciation

    14  

Other noncash charges

    7  

Total 2021 restructuring, impairment and plant closing costs

  $ 40  
         

Cash charges

  $ 34  

Noncash charges:

       

Other noncash charges

    7  

Total 2020 restructuring, impairment and plant closing costs

  $ 41  

 

RESTRUCTURING ACTIVITIES

 

Beginning in the fourth quarter of 2022, we implemented a restructuring program to further realign our cost structure beyond the current in-progress cost optimization programs with additional restructuring in Europe. The new program includes exiting and consolidating certain facilities, workforce relocation to lower cost locations and further personnel rationalization. In connection with this program, we recorded net restructuring expense of approximately $34 million for the year ended December 31, 2022, primarily related to workforce reductions. We expect to record further restructuring expenses of approximately $12 million through 2023.

 

Beginning in the third quarter of 2022, our Corporate function implemented restructuring programs to optimize our global approaches to leveraging managed services in various information technology functions and to align and optimize our supply chain and EHS processes and systems. In connection with these restructuring programs, we recorded net restructuring expense of approximately $19 million for the year ended December 31, 2022, primarily related to workforce reductions. We expect to record further restructuring expenses of approximately $1 million through 2023. 

 

Beginning in the first quarter of 2021, our Corporate function implemented a restructuring program to optimize our global approach to leveraging shared services capabilities. During the second quarter of 2022, this program was further expanded to include additional geographies. In connection with this restructuring program, we recorded net restructuring expense of approximately $15 million and $16 million for the years ended  December 31, 2022 and 2021, respectively, primarily related to workforce reductions. We expect to record further restructuring expenses of approximately $1 million through 2023.

 

Beginning in the third quarter of 2020, our Polyurethanes segment implemented a restructuring program to optimize its downstream footprint. During the second quarter of 2022, this optimization program was further expanded to include the entire Polyurethanes business. In connection with this restructuring program, we recorded net restructuring expense of approximately $10 million, $7 million and $12 million for the years ended December 31, 2022, 2021 and 2020, respectively. During 2022, this net expense primarily related to workforce reductions. During 2021, this net expense primarily related to workforce reductions and accelerated depreciation, partially offset by a gain on the sale of assets of approximately $3 million. During 2020, this expense primarily related to workforce reductions. We expect to record further restructuring expenses of approximately $4 million through 2023.

 

Beginning in the second quarter of 2020, our Advanced Materials segment implemented restructuring programs in connection with the CVC Thermoset Specialties Acquisition, the alignment of the segment’s commercial organization and optimization of the segment’s manufacturing processes. In connection with these restructuring programs, we recorded net restructuring expense of approximately $8 million, $10 million and $10 million for the years ended December 31, 2022, 2021 and 2020, respectively. During 2022 and 2021, this net expense primarily related to accelerated depreciation. During 2020, this net expense primarily related to workforce reductions and accelerated depreciation. We expect to record further restructuring expenses of approximately $3 million through the end of 2023.

 

Beginning in the second quarter of 2020, our Polyurethanes segment implemented a restructuring program to reorganize its spray polyurethane foam business to better position this business for efficiencies and growth in coming years. In connection with this restructuring program, we recorded net restructuring expense of approximately $9 million for the year ended December 31, 2020, primarily related to workforce reductions and accelerated depreciation. 

 

Beginning in the second quarter of 2020, our Performance Products segment implemented a restructuring program, primarily related to workforce reductions, in response to the sale of our Chemical Intermediates Businesses to Indorama. In connection with this restructuring program, we recorded net restructuring expense of approximately $4 million for the year ended December 21, 2020.